Elixxer Ltd. (ELXR.V)

1.1500 0.0000 (0.00%) At close: 03:09PM EDT

Elixxer Ltd.

1100 Boulevard Rene- Levesque Ouest
Suite 700
Montreal, QC H5B 4N4
Canada

https://www.elixxer.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Ferras Zalt	Chairman & Interim CEO	330.89k	N/A	1963
Ms. Kym No C.M.A., CPA	Corporate Controller & Interim CFO	170k	N/A	N/A
Mr. Guy Charette L.L.B., LL.B.	Legal Council	N/A	N/A	1954
Ms. Jeanne van Wyk	Vice President of Communications	N/A	N/A	N/A
Mr. Daniel Lubienietzky	VP of Corporate Development	N/A	N/A	N/A
Mr. Richard Widmann	EVP of Commercial	N/A	N/A	1968
Mr. Michael Kozub	Corporate Secretary	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.

Corporate Governance

Elixxer Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.